Latest receivables for SUS.ST: $330M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), SUS.ST shows a receivables of $330M. That compares with $320M in the prior-year period — up 4.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SUS.ST's receivables is now $330M (was $320M) — a 4.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Surgical Science Sweden AB (publ) is outperforming or lagging.
Tracking SUS.ST's receivables over time shows whether Surgical Science Sweden AB (publ) is scaling, shrinking, or reshaping that part of the business. The current reading is $330M That compares with $320M in the prior-year period — up 4.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Surgical Science Sweden AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $330M) with ownership activity and broader fundamentals.